Shareholding disclosure
Cystic Fibrosis Foundation
Declared position
13.45%
Threshold
Crossed upwards
Timeline
Published
07.01.2022
Transaction
29.12.2021
Transfer date
03.01.2022
Voting rights breakdown
Voting rights acquired13.45%
Voting rights sold0%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAM1500083
Beneficial owner
Cystic Fibrosis Foundation
Declared address
Cystic Fibrosis Foundation, Bethesda, MD 20814,
Subscription of shares to be issued from an ordinary capital increase of Polyphor AG approved on 28 October 2021 in connection with the proposed combination with EnBiotix, Inc. The shares will be issued to the holders of EnBiotix capital stock who subscribe for Polyhpor shares against contribution of their EnBiotix shares upon closing of the combination.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open